✦ LIBER ✦

Molecular response to first line nilotinib in a patient with e19a2 BCR–ABL1 chronic myeloid leukemia

✍ Scribed by Stephen E. Langabeer; Sarah L. McCarron; Peig Carroll; Johanna Kelly; Michael O’Dwyer; Eibhlin Conneally

Book ID: 113773443
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 138 KB
Volume: 35
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2011.05.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rapid initial decline in BCR-ABL1 is ass

Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia

✍ Andrew M Stein, Giovanni Martinelli, Timothy P Hughes, Martin C Müller… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 256 KB

Low-level Bcr–Abl mutations are very rar

Low-level Bcr–Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib

✍ Simona Soverini; Alessandra Gnani; Caterina De Benedittis; Fausto Castagnetti; G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Major molecular response to imatinib in

Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript

✍ Tchirkov, A; Couderc, J-L; Périssel, B; Goumy, C; Regnier, A; Uhrhammer, N; Verr 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 94 KB

Imatinib induces a cytogenetic response

Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts

✍ Lee, J-J; Kim, H-J; Kim, Y-J; Lee, S; Hwang, J-Y; Kim, Y-L; Kim, D-W 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

First and second line imatinib treatment

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts

✍ Hajnalka Andrikovics; Sarolta Nahajevszky; Anikó Szilvási; András Bors; Emma Ádá 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract During the formation of the Philadelphia (Ph) chromosome, in the majority of chronic myelogenous leukemia (CML) patients, the chromosome 22 breakpoint is located in the major breakpoint cluster region of the BCR gene (M‐bcr). Minor and micro breakpoint cluster regions (m‐bcr with e1a2 t

Insertion of a genomic fragment of chrom

Insertion of a genomic fragment of chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic myeloid leukaemia patient with μ-BCR-ABL (e19a2) transcript

✍ Takuo Ito; Hideo Tanaka; Kimio Tanaka; Kinro Ito; Taiichi Kyo; Hiroo Dohy; Nanao 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB